APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medications for Treating Alcohol Dependence

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medications for Treating Alcohol Dependence Market Outlook and Growth Opportunities 2026

21 December 2025196 pages

Choose your research edition.

Industry ResearchMedications for Treating Alcohol Dependence Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Medications for Treating Alcohol Dependence Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Medications for Treating Alcohol Dependence Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medications for Treating Alcohol Dependence Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Medications for Treating Alcohol Dependence Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Medications for Treating Alcohol Dependence market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medications for Treating Alcohol Dependence is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medications for Treating Alcohol Dependence is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medications for Treating Alcohol Dependence is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medications for Treating Alcohol Dependence market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medications for Treating Alcohol Dependence market include Teva, Sun Pharmaceutical Industries, Merck Group, Mylan, Zydus Pharmaceuticals, Glenmark Pharmaceuticals, Beijing Wellso Pharmaceutical Co, Taj Pharmaceuticals and TAGI Pharma Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medications for Treating Alcohol Dependence market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medications for Treating Alcohol Dependence and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medications for Treating Alcohol Dependence revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medications for Treating Alcohol Dependence market.

Medications for Treating Alcohol Dependence Segment by Company

Teva

Sun Pharmaceutical Industries

Merck Group

Mylan

Zydus Pharmaceuticals

Glenmark Pharmaceuticals

Beijing Wellso Pharmaceutical Co

Taj Pharmaceuticals

TAGI Pharma Inc.

Rusan Pharma Ltd

Lundbeck

Alvogen

Alkermes Inc

Medications for Treating Alcohol Dependence Segment by Type

Disulfiram

Naltrexone

Acamprosate

Other

Medications for Treating Alcohol Dependence Segment by Application

Clinic

Hospital

Retail Pharmacies

Rehabilitation Institutions

Medications for Treating Alcohol Dependence Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medications for Treating Alcohol Dependence status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medications for Treating Alcohol Dependence key companies, revenue, market share, and recent developments.

3. To split the Medications for Treating Alcohol Dependence breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medications for Treating Alcohol Dependence market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medications for Treating Alcohol Dependence significant trends, drivers, influence factors in global and regions.

6. To analyze Medications for Treating Alcohol Dependence competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medications for Treating Alcohol Dependence market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medications for Treating Alcohol Dependence and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medications for Treating Alcohol Dependence.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medications for Treating Alcohol Dependence industry.

Chapter 3: Detailed analysis of Medications for Treating Alcohol Dependence company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medications for Treating Alcohol Dependence in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medications for Treating Alcohol Dependence in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medications for Treating Alcohol Dependence Industry Trends Table 2. Medications for Treating Alcohol Dependence Industry Drivers Table 3. Medications for Treating Alcohol Dependence Industry Opportunities and Challenges Table 4. Medications for Treating Alcohol Dependence Industry Restraints Table 5. Global Medications for Treating Alcohol Dependence Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medications for Treating Alcohol Dependence Revenue Share by Company (2021-2026) Table 7. Global Medications for Treating Alcohol Dependence Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medications for Treating Alcohol Dependence Key Company Manufacturing Base & Headquarters Table 9. Global Medications for Treating Alcohol Dependence Company, Product Type & Application Table 10. Global Medications for Treating Alcohol Dependence Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medications for Treating Alcohol Dependence by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Disulfiram Table 15. Significant Companies of Naltrexone Table 16. Significant Companies of Acamprosate Table 17. Significant Companies of Other Table 18. Global Medications for Treating Alcohol Dependence Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Medications for Treating Alcohol Dependence Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Medications for Treating Alcohol Dependence Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Medications for Treating Alcohol Dependence Sales Value Share by Type (2021-2026) Table 22. Global Medications for Treating Alcohol Dependence Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Clinic Table 24. Significant Companies of Hospital Table 25. Significant Companies of Retail Pharmacies Table 26. Significant Companies of Rehabilitation Institutions Table 27. Global Medications for Treating Alcohol Dependence Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Medications for Treating Alcohol Dependence Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Medications for Treating Alcohol Dependence Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Medications for Treating Alcohol Dependence Sales Value Share by Application (2021-2026) Table 31. Global Medications for Treating Alcohol Dependence Sales Value Share by Application (2027-2032) Table 32. Global Medications for Treating Alcohol Dependence Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Medications for Treating Alcohol Dependence Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Medications for Treating Alcohol Dependence Sales Value Share by Region (2021-2026) Table 35. Global Medications for Treating Alcohol Dependence Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Medications for Treating Alcohol Dependence Sales Value Share by Region (2027-2032) Table 37. Global Medications for Treating Alcohol Dependence Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Medications for Treating Alcohol Dependence Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Medications for Treating Alcohol Dependence Sales Value Market Share by Country (2021-2026) Table 40. Global Medications for Treating Alcohol Dependence Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Medications for Treating Alcohol Dependence Sales Value Market Share by Country (2027-2032) Table 42. Teva Company Information Table 43. Teva Business Overview Table 44. Teva Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Teva Medications for Treating Alcohol Dependence Product Portfolio Table 46. Teva Recent Development Table 47. Sun Pharmaceutical Industries Company Information Table 48. Sun Pharmaceutical Industries Business Overview Table 49. Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Product Portfolio Table 51. Sun Pharmaceutical Industries Recent Development Table 52. Merck Group Company Information Table 53. Merck Group Business Overview Table 54. Merck Group Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Merck Group Medications for Treating Alcohol Dependence Product Portfolio Table 56. Merck Group Recent Development Table 57. Mylan Company Information Table 58. Mylan Business Overview Table 59. Mylan Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Mylan Medications for Treating Alcohol Dependence Product Portfolio Table 61. Mylan Recent Development Table 62. Zydus Pharmaceuticals Company Information Table 63. Zydus Pharmaceuticals Business Overview Table 64. Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio Table 66. Zydus Pharmaceuticals Recent Development Table 67. Glenmark Pharmaceuticals Company Information Table 68. Glenmark Pharmaceuticals Business Overview Table 69. Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio Table 71. Glenmark Pharmaceuticals Recent Development Table 72. Beijing Wellso Pharmaceutical Co Company Information Table 73. Beijing Wellso Pharmaceutical Co Business Overview Table 74. Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Product Portfolio Table 76. Beijing Wellso Pharmaceutical Co Recent Development Table 77. Taj Pharmaceuticals Company Information Table 78. Taj Pharmaceuticals Business Overview Table 79. Taj Pharmaceuticals Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Taj Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio Table 81. Taj Pharmaceuticals Recent Development Table 82. TAGI Pharma Inc. Company Information Table 83. TAGI Pharma Inc. Business Overview Table 84. TAGI Pharma Inc. Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. TAGI Pharma Inc. Medications for Treating Alcohol Dependence Product Portfolio Table 86. TAGI Pharma Inc. Recent Development Table 87. Rusan Pharma Ltd Company Information Table 88. Rusan Pharma Ltd Business Overview Table 89. Rusan Pharma Ltd Medications for Treating Alcohol Dependence Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Rusan Pharma Ltd Medications for Treating Alcohol Dependence Product Portfolio Table 91. Rusan Pharma Ltd Recent Development Table 92. Lundbeck Company Information Table 93. Lundbeck Business Overview Table 94. Lundbeck Medications for Treating Alcohol Dependence Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Lundbeck Medications for Treating Alcohol Dependence Product Portfolio Table 96. Lundbeck Recent Development Table 97. Alvogen Company Information Table 98. Alvogen Business Overview Table 99. Alvogen Medications for Treating Alcohol Dependence Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Alvogen Medications for Treating Alcohol Dependence Product Portfolio Table 101. Alvogen Recent Development Table 102. Alkermes Inc Company Information Table 103. Alkermes Inc Business Overview Table 104. Alkermes Inc Medications for Treating Alcohol Dependence Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Alkermes Inc Medications for Treating Alcohol Dependence Product Portfolio Table 106. Alkermes Inc Recent Development Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Medications for Treating Alcohol Dependence Product Image Figure 2. Global Medications for Treating Alcohol Dependence Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medications for Treating Alcohol Dependence Market Size (2021-2032) & (US$ Million) Figure 4. Global Medications for Treating Alcohol Dependence Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Disulfiram Image Figure 8. Naltrexone Image Figure 9. Acamprosate Image Figure 10. Other Image Figure 11. Global Medications for Treating Alcohol Dependence Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Medications for Treating Alcohol Dependence Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Medications for Treating Alcohol Dependence Sales Value Share by Type (2021-2032) Figure 14. Clinic Image Figure 15. Hospital Image Figure 16. Retail Pharmacies Image Figure 17. Rehabilitation Institutions Image Figure 18. Global Medications for Treating Alcohol Dependence Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Medications for Treating Alcohol Dependence Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Medications for Treating Alcohol Dependence Sales Value Share by Application (2021-2032) Figure 21. Global Medications for Treating Alcohol Dependence Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Medications for Treating Alcohol Dependence Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Medications for Treating Alcohol Dependence Sales Value (2021-2032) & (US$ Million) Figure 24. North America Medications for Treating Alcohol Dependence Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Medications for Treating Alcohol Dependence Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Medications for Treating Alcohol Dependence Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Medications for Treating Alcohol Dependence Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Medications for Treating Alcohol Dependence Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Medications for Treating Alcohol Dependence Sales Value (2021-2032) & (US$ Million) Figure 30. South America Medications for Treating Alcohol Dependence Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Medications for Treating Alcohol Dependence Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Medications for Treating Alcohol Dependence Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Disulfiram
  • Naltrexone
  • Acamprosate
  • Other
Applications
  • Clinic
  • Hospital
  • Retail Pharmacies
  • Rehabilitation Institutions
Companies covered
  • Teva
  • Sun Pharmaceutical Industries
  • Merck Group
  • Mylan
  • Zydus Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Beijing Wellso Pharmaceutical Co
  • Taj Pharmaceuticals
  • TAGI Pharma Inc.
  • Rusan Pharma Ltd
  • Lundbeck
  • Alvogen
  • Alkermes Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medications for Treating Alcohol Dependence Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medications for Treating Alcohol Dependence Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medications for Treating Alcohol Dependence Market Dynamics
  1. 2.1 Medications for Treating Alcohol Dependence Industry Trends
  2. 2.2 Medications for Treating Alcohol Dependence Industry Drivers
  3. 2.3 Medications for Treating Alcohol Dependence Industry Opportunities and Challenges
  4. 2.4 Medications for Treating Alcohol Dependence Industry Restraints
3 Medications for Treating Alcohol Dependence Market by Company
  1. 3.1 Global Medications for Treating Alcohol Dependence Company Revenue Ranking in 2025
  2. 3.2 Global Medications for Treating Alcohol Dependence Revenue by Company (2021-2026)
  3. 3.3 Global Medications for Treating Alcohol Dependence Company Ranking (2024-2026)
  4. 3.4 Global Medications for Treating Alcohol Dependence Company Manufacturing Base and Headquarters
  5. 3.5 Global Medications for Treating Alcohol Dependence Company Product Type and Application
  6. 3.6 Global Medications for Treating Alcohol Dependence Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medications for Treating Alcohol Dependence Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medications for Treating Alcohol Dependence Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medications for Treating Alcohol Dependence Market by Type
  1. 4.1 Medications for Treating Alcohol Dependence Type Introduction
  2. 4.1.1 Disulfiram
  3. 4.1.2 Naltrexone
  4. 4.1.3 Acamprosate
  5. 4.1.4 Other
  6. 4.2 Global Medications for Treating Alcohol Dependence Sales Value by Type
  7. 4.2.1 Global Medications for Treating Alcohol Dependence Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Medications for Treating Alcohol Dependence Sales Value by Type (2021-2032)
  9. 4.2.3 Global Medications for Treating Alcohol Dependence Sales Value Share by Type (2021-2032)
5 Medications for Treating Alcohol Dependence Market by Application
  1. 5.1 Medications for Treating Alcohol Dependence Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 Rehabilitation Institutions
  6. 5.2 Global Medications for Treating Alcohol Dependence Sales Value by Application
  7. 5.2.1 Global Medications for Treating Alcohol Dependence Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Medications for Treating Alcohol Dependence Sales Value by Application (2021-2032)
  9. 5.2.3 Global Medications for Treating Alcohol Dependence Sales Value Share by Application (2021-2032)
6 Medications for Treating Alcohol Dependence Regional Value Analysis
  1. 6.1 Global Medications for Treating Alcohol Dependence Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medications for Treating Alcohol Dependence Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medications for Treating Alcohol Dependence Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medications for Treating Alcohol Dependence Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medications for Treating Alcohol Dependence Sales Value (2021-2032)
  7. 6.3.2 North America Medications for Treating Alcohol Dependence Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medications for Treating Alcohol Dependence Sales Value (2021-2032)
  10. 6.4.2 Europe Medications for Treating Alcohol Dependence Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medications for Treating Alcohol Dependence Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medications for Treating Alcohol Dependence Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medications for Treating Alcohol Dependence Sales Value (2021-2032)
  16. 6.6.2 South America Medications for Treating Alcohol Dependence Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medications for Treating Alcohol Dependence Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medications for Treating Alcohol Dependence Sales Value Share by Country, 2025 VS 2032
7 Medications for Treating Alcohol Dependence Country-level Value Analysis
  1. 7.1 Global Medications for Treating Alcohol Dependence Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medications for Treating Alcohol Dependence Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medications for Treating Alcohol Dependence Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medications for Treating Alcohol Dependence Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medications for Treating Alcohol Dependence Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medications for Treating Alcohol Dependence Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medications for Treating Alcohol Dependence Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Medications for Treating Alcohol Dependence Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharmaceutical Industries
  8. 8.2.1 Sun Pharmaceutical Industries Company Information
  9. 8.2.2 Sun Pharmaceutical Industries Business Overview
  10. 8.2.3 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Industries Recent Developments
  13. 8.3 Merck Group
  14. 8.3.1 Merck Group Company Information
  15. 8.3.2 Merck Group Business Overview
  16. 8.3.3 Merck Group Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Group Medications for Treating Alcohol Dependence Product Portfolio
  18. 8.3.5 Merck Group Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Medications for Treating Alcohol Dependence Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Zydus Pharmaceuticals
  26. 8.5.1 Zydus Pharmaceuticals Company Information
  27. 8.5.2 Zydus Pharmaceuticals Business Overview
  28. 8.5.3 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio
  30. 8.5.5 Zydus Pharmaceuticals Recent Developments
  31. 8.6 Glenmark Pharmaceuticals
  32. 8.6.1 Glenmark Pharmaceuticals Company Information
  33. 8.6.2 Glenmark Pharmaceuticals Business Overview
  34. 8.6.3 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio
  36. 8.6.5 Glenmark Pharmaceuticals Recent Developments
  37. 8.7 Beijing Wellso Pharmaceutical Co
  38. 8.7.1 Beijing Wellso Pharmaceutical Co Company Information
  39. 8.7.2 Beijing Wellso Pharmaceutical Co Business Overview
  40. 8.7.3 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Product Portfolio
  42. 8.7.5 Beijing Wellso Pharmaceutical Co Recent Developments
  43. 8.8 Taj Pharmaceuticals
  44. 8.8.1 Taj Pharmaceuticals Company Information
  45. 8.8.2 Taj Pharmaceuticals Business Overview
  46. 8.8.3 Taj Pharmaceuticals Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Taj Pharmaceuticals Medications for Treating Alcohol Dependence Product Portfolio
  48. 8.8.5 Taj Pharmaceuticals Recent Developments
  49. 8.9 TAGI Pharma Inc.
  50. 8.9.1 TAGI Pharma Inc. Company Information
  51. 8.9.2 TAGI Pharma Inc. Business Overview
  52. 8.9.3 TAGI Pharma Inc. Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  53. 8.9.4 TAGI Pharma Inc. Medications for Treating Alcohol Dependence Product Portfolio
  54. 8.9.5 TAGI Pharma Inc. Recent Developments
  55. 8.10 Rusan Pharma Ltd
  56. 8.10.1 Rusan Pharma Ltd Company Information
  57. 8.10.2 Rusan Pharma Ltd Business Overview
  58. 8.10.3 Rusan Pharma Ltd Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Rusan Pharma Ltd Medications for Treating Alcohol Dependence Product Portfolio
  60. 8.10.5 Rusan Pharma Ltd Recent Developments
  61. 8.11 Lundbeck
  62. 8.11.1 Lundbeck Company Information
  63. 8.11.2 Lundbeck Business Overview
  64. 8.11.3 Lundbeck Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lundbeck Medications for Treating Alcohol Dependence Product Portfolio
  66. 8.11.5 Lundbeck Recent Developments
  67. 8.12 Alvogen
  68. 8.12.1 Alvogen Company Information
  69. 8.12.2 Alvogen Business Overview
  70. 8.12.3 Alvogen Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Alvogen Medications for Treating Alcohol Dependence Product Portfolio
  72. 8.12.5 Alvogen Recent Developments
  73. 8.13 Alkermes Inc
  74. 8.13.1 Alkermes Inc Company Information
  75. 8.13.2 Alkermes Inc Business Overview
  76. 8.13.3 Alkermes Inc Medications for Treating Alcohol Dependence Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Alkermes Inc Medications for Treating Alcohol Dependence Product Portfolio
  78. 8.13.5 Alkermes Inc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst